Dupilumab and House Dust Mite Immunotherapy in Patients with Atopic Dermatitis: A Preliminary Study
In patients with severe AD and HDM allergies, combination treatment with dupilumab and allergen immunotherapy for HDMs may increase the therapeutic benefit over treatment with these methods separately.
Authors
- Giorgio Walter Canonica (ORCID: https://orcid.org/0000-0001-8467-2557)
- Andrzej Bożek (ORCID: https://orcid.org/0000-0003-2263-2263)
- Jolanta Zalejska–Fiolka (ORCID: https://orcid.org/0000-0002-3879-6548)
- Magdalena Krupka-Olek (ORCID: https://orcid.org/0000-0003-4177-8102)
- Agnieszka Bogacz-Piaseczyńska (ORCID: https://orcid.org/0000-0002-5127-6379)
- Aleksandra Kawczyk‐Krupka (ORCID: https://orcid.org/0000-0003-1284-3809)
Institutions
- Humanitas University (IT)
- Medical University of Silesia (PL)
Publication Details
- Journal
- Vaccines
- Published
- 2024-09-13
- DOI
- https://doi.org/10.3390/vaccines12091046
- Citations
- 4
- Primary Topic
- Dermatology and Skin Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.14